Directorate Change

13th Jun 2025 17:00

RNS Number : 8541M
Octopus Renewables Infra Trust PLC
13 June 2025
 

13 June 2025

 

LEI: 213800B81BFJKWM2JV13

 

 

Octopus Renewables Infrastructure Trust plc

("ORIT" or the "Company")

 

Directorate Changes

 

Further to the Company's previous announcement dated 5 December 2024, Octopus Renewables Infrastructure Trust plc announces that Audrey McNair has retired from the Board and stepped down as Chair of the Audit and Risk Committee with effect from the conclusion of the Company's Annual General Meeting held earlier today on 13 June 2025.

 

The Board is pleased to confirm that, in line with the Company's previously announced succession plans, Sally Duckworth, who was appointed as an independent Non-Executive Director on 21 March 2025, has assumed the role of Chair of the Audit and Risk Committee with immediate effect.

 

The Company once again thanks Audrey her contribution to the Company over the past five years and wishes her well for the future.

 

Enquiries:

 

 

Company Secretary

Apex Listed Companies Services (UK) Limited

 

 

+44 20 3327 9720

 

 

 

About Octopus Renewables Infrastructure Trust

 

Octopus Renewables Infrastructure Trust ("ORIT") is a London-listed, closed-ended investment company incorporated in England and Wales focused on providing investors with an attractive and sustainable level of income returns, with an element of capital growth, by investing in a diversified portfolio of renewable energy assets in Europe and Australia. As an impact fund, ORIT is helping accelerate the transition to net zero by investing in green energy, whilst also contributing to a broader set of UN Sustainable Development Goals through its impact initiatives. ORIT's investment manager is Octopus Energy Generation.  

Further details can be found at www.octopusrenewablesinfrastructure.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUGDLDDBDGUX